Repligen Corp at William Blair Growth Stock Conference Transcript
Good morning, everyone. Welcome to our next session, which is Repligen, one of the most innovative companies in the bioprocessing space. I am John Kreger, I'm the research analyst at Blair that covers Repligen. I am required to inform you that you can obtain a complete list of research disclosures or potential conflicts of interest at williamblair.com.
Thanks for joining us. We're going to take the next 30 minutes to go through a fireside chat with Tony Hunt, the CEO of Repligen. Jon Snodgres, the CFO, is also on the line, and so he may chime in where appropriate. And last logistical comment I will make for all of you participating. There is a chat feature, so you are able to submit questions to me, and I will attempt to work them in time permitting.
So with that, let's kick it off.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |